These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 27391064)
1. In-depth proteomic profiling of the uveal melanoma secretome. Angi M; Kalirai H; Prendergast S; Simpson D; Hammond DE; Madigan MC; Beynon RJ; Coupland SE Oncotarget; 2016 Aug; 7(31):49623-49635. PubMed ID: 27391064 [TBL] [Abstract][Full Text] [Related]
2. iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors. Crabb JW; Hu B; Crabb JS; Triozzi P; Saunthararajah Y; Tubbs R; Singh AD PLoS One; 2015; 10(8):e0135543. PubMed ID: 26305875 [TBL] [Abstract][Full Text] [Related]
3. Expression of the serotonin receptor 2B in uveal melanoma and effects of an antagonist on cell lines. Weidmann C; Bérubé J; Piquet L; de la Fouchardière A; Landreville S Clin Exp Metastasis; 2018 Mar; 35(3):123-134. PubMed ID: 29696577 [TBL] [Abstract][Full Text] [Related]
4. Differential expression of fourteen proteins between uveal melanoma from patients who subsequently developed distant metastases versus those who did Not. Linge A; Kennedy S; O'Flynn D; Beatty S; Moriarty P; Henry M; Clynes M; Larkin A; Meleady P Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4634-43. PubMed ID: 22570344 [TBL] [Abstract][Full Text] [Related]
5. A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins. Elshaw SR; Sisley K; Cross N; Murray AK; MacNeil SM; Wagner M; Nichols CE; Rennie IG Br J Ophthalmol; 2001 Jun; 85(6):732-8. PubMed ID: 11371496 [TBL] [Abstract][Full Text] [Related]
6. c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential. Wu X; Zhou J; Rogers AM; Jänne PA; Benedettini E; Loda M; Hodi FS Melanoma Res; 2012 Apr; 22(2):123-32. PubMed ID: 22343486 [TBL] [Abstract][Full Text] [Related]
7. Analysis of the proteasome activity and the turnover of the serotonin receptor 2B (HTR2B) in human uveal melanoma. Le-Bel G; Benhassine M; Landreville S; Guérin SL Exp Eye Res; 2019 Jul; 184():72-77. PubMed ID: 31002821 [TBL] [Abstract][Full Text] [Related]
8. Proteomic profiling of human melanoma metastatic cell line secretomes. Rocco M; Malorni L; Cozzolino R; Palmieri G; Rozzo C; Manca A; Parente A; Chambery A J Proteome Res; 2011 Oct; 10(10):4703-14. PubMed ID: 21815687 [TBL] [Abstract][Full Text] [Related]
9. Contribution of the STAT Family of Transcription Factors to the Expression of the Serotonin 2B (HTR2B) Receptor in Human Uveal Melanoma. Benhassine M; Le-Bel G; Guérin SL Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163491 [TBL] [Abstract][Full Text] [Related]
10. CD166high Uveal Melanoma Cells Represent a Subpopulation With Enhanced Migratory Capacity. Djirackor L; Kalirai H; Coupland SE; Petrovski G Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2696-2704. PubMed ID: 31242292 [TBL] [Abstract][Full Text] [Related]
11. HIC1 modulates uveal melanoma progression by activating lncRNA-numb. Cheng G; He J; Zhang L; Ge S; Zhang H; Fan X Tumour Biol; 2016 Sep; 37(9):12779-12789. PubMed ID: 27449031 [TBL] [Abstract][Full Text] [Related]
12. Nestin expression in primary and metastatic uveal melanoma - possible biomarker for high-risk uveal melanoma. Djirackor L; Shakir D; Kalirai H; Petrovski G; Coupland SE Acta Ophthalmol; 2018 Aug; 96(5):503-509. PubMed ID: 29338117 [TBL] [Abstract][Full Text] [Related]
13. Molecular characteristics of liver metastases from uveal melanoma. Meir T; Dror R; Yu X; Qian J; Simon I; Pe'er J; Chowers I Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4890-6. PubMed ID: 17962435 [TBL] [Abstract][Full Text] [Related]
14. AHNAK Nucleoprotein 2 Performs a Promoting Role in the Proliferation and Migration of Uveal Melanoma Cells. Li M; Liu Y; Meng Y; Zhu Y Cancer Biother Radiopharm; 2019 Dec; 34(10):626-633. PubMed ID: 31621397 [TBL] [Abstract][Full Text] [Related]